University of Rochester

Johanna I Hamel

23 Sept 2026reporter.nih.gov

Sucrosomial Vs Intravenous Iron for Preoperative Anemia

Phase 4Withdrawn0 people17 Dec 2025clinicaltrials.gov

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

No phaseRecruiting408 people13 Apr 2025clinicaltrials.gov

NCT06068543

Phase 2Suspended118 people5 Oct 2023clinicaltrials.gov

NCT05838716

Phase 3Recruiting240 people1 May 2023clinicaltrials.gov

NCT05797506

Phase 2Completed96 people4 Apr 2023clinicaltrials.gov

NCT05653492

Phase 2Active, not recruiting12 people16 Dec 2022clinicaltrials.gov

NCT05571319

CollaboratorPhase 2Completed30 people7 Oct 2022clinicaltrials.gov

NCT05153174

Phase 1Completed18 people10 Dec 2021clinicaltrials.gov

NCT04792190

Phase 4Completed25 people10 Mar 2021clinicaltrials.gov

NCT04731844

Phase 2Completed30 people1 Feb 2021clinicaltrials.gov

NCT04635189

Phase 2Active, not recruiting28 people19 Nov 2020clinicaltrials.gov

NCT04594798

Phase 2Active, not recruiting39 people20 Oct 2020clinicaltrials.gov

NCT04553666

Phase 2Completed24 people17 Sept 2020clinicaltrials.gov

NCT04200066

Phase 1Withdrawn0 people16 Dec 2019clinicaltrials.gov

NCT04098666

CollaboratorPhase 2/3Active, not recruiting326 people23 Sept 2019clinicaltrials.gov

NCT03839459

Phase 2Completed20 people15 Feb 2019clinicaltrials.gov

NCT03758989

Phase 2Recruiting40 people29 Nov 2018clinicaltrials.gov

NCT03746041

Phase 1Completed20 people19 Nov 2018clinicaltrials.gov

NCT03367572

Phase 3Completed1,363 people8 Dec 2017clinicaltrials.gov

NCT03275857

Early phase 1Completed12 people8 Sept 2017clinicaltrials.gov

Food and Drug Administration

Calcium Channel Blocker in Myotonic Dystrophy Type 1 (CAP DM1)R01FD008510US$1.3m23 Sept 2026reporter.nih.gov